Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment

The article deals with the problem of metabolic syndrome and the development of liver failure in patients with this disease. The authors provide evidence about the advisability of administration to such patients of combined medication — ornithine aspartate (original ornithine aspartate Hepa-Merz pro...

Full description

Bibliographic Details
Main Authors: V.V. Cherniavskyi, A.K. Sizenko
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2014-11-01
Series:Gastroenterologìa
Subjects:
Online Access:http://gastro.zaslavsky.com.ua/article/view/82022
_version_ 1818918704480518144
author V.V. Cherniavskyi
A.K. Sizenko
author_facet V.V. Cherniavskyi
A.K. Sizenko
author_sort V.V. Cherniavskyi
collection DOAJ
description The article deals with the problem of metabolic syndrome and the development of liver failure in patients with this disease. The authors provide evidence about the advisability of administration to such patients of combined medication — ornithine aspartate (original ornithine aspartate Hepa-Merz produced by Merz Pharma GmbH & Co.). Efficiency of Hepa-Merz manifests by a decrease in hepatocyte cytolysis, normalization of lipid and carbohydrate metabolism, as well as positive effects on the clinical presentation of hepatic encephalopathy.
first_indexed 2024-12-20T00:54:12Z
format Article
id doaj.art-508b3f23852547608cf8cf28ea9eb926
institution Directory Open Access Journal
issn 2308-2097
2518-7880
language English
last_indexed 2024-12-20T00:54:12Z
publishDate 2014-11-01
publisher Zaslavsky O.Yu.
record_format Article
series Gastroenterologìa
spelling doaj.art-508b3f23852547608cf8cf28ea9eb9262022-12-21T19:59:09ZengZaslavsky O.Yu.Gastroenterologìa2308-20972518-78802014-11-01484.54707510.22141/2308-2097.4.54.2014.8202282022Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic TreatmentV.V. Cherniavskyi0A.K. Sizenko1National Medical University named after A.A. Bohomolets, Kyiv, UkraineNational Medical University named after A.A. Bohomolets, Kyiv, UkraineThe article deals with the problem of metabolic syndrome and the development of liver failure in patients with this disease. The authors provide evidence about the advisability of administration to such patients of combined medication — ornithine aspartate (original ornithine aspartate Hepa-Merz produced by Merz Pharma GmbH & Co.). Efficiency of Hepa-Merz manifests by a decrease in hepatocyte cytolysis, normalization of lipid and carbohydrate metabolism, as well as positive effects on the clinical presentation of hepatic encephalopathy.http://gastro.zaslavsky.com.ua/article/view/82022metabolic syndromeliverornithine aspartateHepa-Merz
spellingShingle V.V. Cherniavskyi
A.K. Sizenko
Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment
Gastroenterologìa
metabolic syndrome
liver
ornithine aspartate
Hepa-Merz
title Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment
title_full Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment
title_fullStr Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment
title_full_unstemmed Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment
title_short Hepatological Aspects of Metabolic Syndrome and Possibilities of Pathogenetic Treatment
title_sort hepatological aspects of metabolic syndrome and possibilities of pathogenetic treatment
topic metabolic syndrome
liver
ornithine aspartate
Hepa-Merz
url http://gastro.zaslavsky.com.ua/article/view/82022
work_keys_str_mv AT vvcherniavskyi hepatologicalaspectsofmetabolicsyndromeandpossibilitiesofpathogenetictreatment
AT aksizenko hepatologicalaspectsofmetabolicsyndromeandpossibilitiesofpathogenetictreatment